Browse By: Country ι Category ι Tag
Home  »  Drug Discovery

Drug Discovery Market Research Reports

More

ADME/Tox Technologies
This report on ADME/Tox Technologies gives a market insight into products and services used in the ADME/Tox industry. Predictive technologies analyzed include In vivo, In vitro, and In silico. Related technologies such as High Throughput Screening (HTS), Laboratory Information Management System (LIMS), and cell based assays are also analyzed.
Published Date: Apr 2016
Published By: RI Technologies

Price: $3600
GPCR - Drug Targets
?Market research report on G-Protein Coupled Receptors (GPCR) covers the types of GPCR Families and the various ligands targeting GPCR. The GPCR families covered include Rhodopsin, Secretin, Metabotropic glutamate and Other. The Ligands targeting GPCRs include Peptides or Proteins, Biogenic Amines, Lipids and Other. The report provides market analysis of each of the Families and ligands targeting GPCRs by their respective categories. 
Published Date: Apr 2016
Published By: RI Technologies

Price: $3600
High Throughput Screening
This report on High Throughput Screening (HTS) emphasizes on both the technology and product segments of HTS in biotechnology and pharmaceutical application areas. The major technologies analyzed include Ultra High Throughput Screening, High Content Screening, Bioinformatics and Microfluidics/Lab-On-a-Chip; and the major product segments encompass HTS Services and HTS Tools.
Published Date: Mar 2016
Published By: RI Technologies

Price: $3780
Global Parasitic Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
Published Date: Mar 2016
Published By: Current Partnering

Price: $1495
Global Herpes simplex Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
Published Date: Mar 2016
Published By: Current Partnering

Price: $1495
Global Sepsis Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
Published Date: Mar 2016
Published By: Current Partnering

Price: $1495
Global MRSA Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
Published Date: Mar 2016
Published By: Current Partnering

Price: $1495
Global Chronic Kidney Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
Published Date: Mar 2016
Published By: Current Partnering

Price: $1495
Global Retinopathy Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
Published Date: Mar 2016
Published By: Current Partnering

Price: $1495
Global Liver Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
Published Date: Mar 2016
Published By: Current Partnering

Price: $1495
Drug Delivery System Companies in China
This study focuses on China’s Drug Delivery System industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products.
Published Date: Oct 2015
Published By: Asia Market Information & Development Company

Price: $1800
HIV Treatment Drugs Companies in China
This study focuses on China’s HIV Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy.
Published Date: Oct 2015
Published By: Asia Market Information & Development Company

Price: $1800
Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 265 tables & figures within 182 pages. The Chinese biopharmaceutical market is presented as follows:
Published Date: Jul 2015
Published By: Kelly Scientific Publications

Price: $3400
Global Retinopathy Partnering 2010-2015
The Retinopathy Partnering 2010-2015 report provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in retinopathy partnering deals Top retinopathy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Retinopathy Partnering 2010-2015 provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of retinopathy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors retinopathy technology. These deals tend to be multicomponent, star
Published Date: Jun 2015
Published By: Current Partnering

Price: $1495
mTORC - 2 Inhibitors - Pipeline Insights, 2015
DelveInsight’s, mTORC-2 Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the mTORC-2 Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The mTORC-2 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, mTORC-2 Inhibitors- Pipeline Insights, 2015 Report covers the mTORC-2 Inhibitors pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provid
Published Date: May 2015
Published By: DelveInsight

Price: $1250
Inflammatory Partnering 2010-2015
The Inflammatory Partnering 2010-2015 report provides understanding and access to the inflammatory partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in inflammatory partnering deals Top inflammatory deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Inflammatory Partnering 2010-2015 provides understanding and access to the inflammatory partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of inflammatory partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors inflammatory technology. These deals tend to be multicompone
Published Date: May 2015
Published By: Current Partnering

Price: $995
AIDS Partnering 2010-2015
The AIDS Partnering 2010-2015 report provides understanding and access to the AIDS partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in AIDS partnering deals Top AIDS deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The AIDS Partnering 2010-2015 provides understanding and access to the AIDS partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of AIDS partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors AIDS technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercializati
Published Date: May 2015
Published By: Current Partnering

Price: $795
Parasitic Disease Partnering 2010-2015
The Parasitic Partnering 2010-2015 report provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in parasitic partnering deals Top parasitic deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Parasitic Partnering 2010-2015 provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of parasitic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors parasitic technology. These deals tend to be multicomponent, starting wit
Published Date: May 2015
Published By: Current Partnering

Price: $795
Arrhythmia Partnering 2010-2015
The Arrhythmia Partnering 2010-2015 report provides understanding and access to the arrhythmia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in arrhythmia partnering deals Top arrhythmia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Arrhythmia Partnering 2010-2015 provides understanding and access to the arrhythmia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of arrhythmia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors arrhythmia technology. These deals tend to be multicomponent, star
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Thromboembolism - Pipeline Review, H1 2015
Global Markets Directs, Thromboembolism Pipeline Review, H1 2015, provides an overview of the Thromboembolisms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thromboembolism and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data an
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000

Back To Top